Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 4/2020

01-12-2020 | Polysomnography | Sleep Breathing Physiology and Disorders • Original Article

The PAP-NAP one decade later: patient risk factors, indications, and clinically relevant emotional and motivational influences on PAP use

Authors: Victor A. Ulibarri, Barry Krakow, Natalia D. McIver

Published in: Sleep and Breathing | Issue 4/2020

Login to get access

Abstract

Study objectives

Positive airway pressure (PAP) noncompliance remains a major barrier in obstructive sleep apnea (OSA) treatment. The PAP-NAP, a daytime PAP “test-drive,” has been associated with increased PAP use, but risk factors and indications for the procedure remain unspecified.

Methods

A retrospective chart review was conducted on 139 patients who (1) were diagnosed with OSA (n = 116) or upper airway resistance syndrome (UARS) (n = 23); (2) adamantly refused to proceed with either a full-night attended titration or in-home trial of PAP; and (3) elected to proceed with a PAP-NAP instead. Risk factors for PAP rejection (identified on intake) and indications for the PAP-NAP (identified post-diagnostic polysomnography) were confirmed through multiple encounters with sleep center personnel. All patients completed the PAP-NAP, which utilizes an elaborate desensitization program to provide a less challenging introduction and facilitate a gentler adaptation to pressurized air as well as to test advanced PAP modes when subjective or objective expiratory pressure intolerance emerges. Both emotional aversion toward and lack of motivation for PAP therapy were assessed pre- and post-PAP-NAP. PAP use was determined several months post-procedure.

Results

At intake, most common risk factors for PAP rejection were depression, insomnia, and claustrophobia; most common indications for PAP-NAP were general reluctance, anxiety, and claustrophobia. Procedure averaged 3+ hours [tech coaching, 83 (± 30) min; napping, 107 (± 57) min]. Ninety-nine percent required advanced PAP. Compared to baseline, emotional aversion (p = 0.0001) and motivation (p = 0.0001) significantly improved for the entire sample of which 86% completed full-night titrations and 78% filled PAP prescriptions. At final follow-up, 71% (n = 98) were users and 29% (n = 41) were non-users. Compared to non-users, users showed significantly greater decreases in emotional aversion (p <  0.001; Z = − 6.11) and greater increases in motivation (p <  0.001; Z = − 8.57).

Conclusion

PAP-NAP was associated with a sizeable proportion of highly reluctant patients proceeding to titrations they initially had rejected, and the majority achieved PAP user status. Improvements in emotional aversion and motivation were associated with increased PAP use. Randomized control trials must assess the experiential component at the core of the PAP-NAP procedure and its efficacy in reversing early PAP rejecters.
Appendix
Available only for authorised users
Literature
1.
Kimoff RJ (1996) Sleep fragmentation in obstructive sleep apnea. Sleep 19(9 Suppl):S61–S66PubMed
2.
Hudgel DW (1992) Mechanisms of obstructive sleep apnea. Chest 101(2):541–549PubMed
3.
Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165(9):1217–1239PubMed
4.
Bucks RS, Olaithe M, Rosenzweig I et al (2017) Reviewing the relationship between OSA and cognition: where do we go from here? Respirology 22(7):1253–1261PubMed
5.
Batool-Anwar S, Goodwin JL, Kushida CA, Walsh JA, Simon RD, Nichols DA, Quan SF (2016) Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res 25(6):731–738PubMedPubMedCentral
6.
Gurubhagavatula I, Sullivan S, Meoli A et al (2017) Management of obstructive sleep apnea in commercial motor vehicle operators: recommendations of the AASM sleep and transportation safety awareness task force. J Clin Sleep Med 13(5):745–758PubMedPubMedCentral
7.
Garbarino S, Guglielmi O, Sanna A, Mancardi GL, Magnavita N (2016) Risk of occupational accidents in workers with obstructive sleep apnea: systematic review and meta-analysis. Sleep 39(6):1211–1218PubMedPubMedCentral
8.
Harris M, Glozier N, Ratnavadivel R et al (2009) Obstructive sleep apnea and depression. Sleep Med Rev 13(6):437–444PubMed
9.
Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, Malhotra A, Martinez-Garcia MA, Mehra R, Pack AI, Polotsky VY, Redline S, Somers VK (2017) Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol 69(7):841–858PubMedPubMedCentral
10.
Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D (2015) Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens 29(12):705–712PubMed
11.
Martinez-Garcia MA, Campos-Rodriguez F, Catalan-Serra P et al (2012) Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. Am J Respir Crit Care Med 186(9):909–916PubMed
12.
Mesarwi OA, Sharma EV, Jun JC, Polotsky VY (2015) Metabolic dysfunction in obstructive sleep apnea: a critical examination of underlying mechanisms. Sleep Biol Rhythms 13(1):2–17PubMed
13.
Qian Y, Xu H, Wang Y, Yi H, Guan J, Yin S (2016) Obstructive sleep apnea predicts risk of metabolic syndrome independently of obesity: a meta-analysis. Arch Med Sci 12(5):1077–1087PubMedPubMedCentral
14.
Kim Y, Koo YS, Lee HY et al (2016) Can continuous positive airway pressure reduce the risk of stroke in obstructive sleep apnea patients? A systematic review and meta-analysis. PLoS One 11(1):e0146317PubMedPubMedCentral
15.
Barcelo A, Pierola J, Esquinas C et al (2014) Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment. PLoS One 9(1):e84362PubMedPubMedCentral
16.
Gupta MA, Simpson FC, Lyons DC (2016) The effect of treating obstructive sleep apnea with positive airway pressure on depression and other subjective symptoms: a systematic review and meta-analysis. Sleep Med Rev 28:55–68PubMed
17.
Quan SF, Chan CS, Dement WC et al (2011) The association between obstructive sleep apnea and neurocognitive performance--the apnea positive pressure long-term efficacy study (APPLES). Sleep 34(3):303–314BPubMedPubMedCentral
18.
Kuhn E, Schwarz EI, Bratton DJ, Rossi VA, Kohler M (2017) Effects of CPAP and mandibular advancement devices on health-related quality of life in OSA: a systematic review and meta-analysis. Chest 151(4):786–794PubMed
19.
Woods CM, Gunawardena I, Chia M et al (2016) Long-term quality-of-life outcomes following treatment for adult obstructive sleep apnoea: comparison of upper airway surgery, continuous positive airway pressure and mandibular advancement splints. Clin Otolaryngol 41(6):762–770PubMed
20.
Sawyer AM, King TS, Hanlon A et al (2014) Risk assessment for CPAP nonadherence in adults with newly diagnosed obstructive sleep apnea: preliminary testing of the index for nonadherence to PAP (I-NAP). Sleep Breath 18(4):875–883PubMedPubMedCentral
21.
Gordon A, Wu SJ, Munns N et al (2018) Untreated sleep apnea: an analysis of administrative data to identify risk factors for early nonadherence. J Clin Sleep Med;14(8):1303-1313.
22.
Rotenberg BW, Murariu D, Pang KP (2016) Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg 45(1):43PubMedPubMedCentral
23.
Schwab RJ, Badr SM, Epstein LJ, Gay PC, Gozal D, Kohler M, Lévy P, Malhotra A, Phillips BA, Rosen IM, Strohl KP, Strollo PJ, Weaver EM, Weaver TE, ATS Subcommittee on CPAP Adherence Tracking Systems (2013) An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. The optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med 188(5):613–620PubMedPubMedCentral
24.
Weaver TE, Calik MW, Farabi SS, Fink AM, Galang-Boquiren MT, Kapella MC, Prasad B, Carley DW (2014) Innovative treatments for adults with obstructive sleep apnea. Nat Sci Sleep 6:137–147PubMedPubMedCentral
25.
Riachy M, Najem S, Iskandar M, Choucair J, Ibrahim I, Juvelikian G (2017) Factors predicting CPAP adherence in obstructive sleep apnea syndrome. Sleep Breath 21(2):295–302PubMed
26.
Chai-Coetzer CL, Luo YM, Antic NA, Zhang XL, Chen BY, He QY, Heeley E, Huang SG, Anderson C, Zhong NS, McEvoy R (2013) Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study. Sleep 36(12):1929–1937PubMedPubMedCentral
27.
Ball N, Gordon N, Casal E et al (2011) Evaluation of auto bi-level algorithm to treat pressure intolerance in obstructive sleep apnea. Sleep Breath 15(3):301–309PubMed
28.
Gentina T, Fortin F, Douay B, Dernis JM, Herengt F, Bout JC, Lamblin C (2011) Auto bi-level with pressure relief during exhalation as a rescue therapy for optimally treated obstructive sleep apnoea patients with poor compliance to continuous positive airways pressure therapy--a pilot study. Sleep Breath 15(1):21–27PubMed
29.
Krakow B, Ulibarri VA, McIver ND, Yonemoto C, Tidler A, Obando J, Foley-Shea MR, Ornelas J, Dawson S (2017) Reversal of PAP failure with the REPAP protocol. Respir Care 62(4):396–408PubMed
30.
Bollig SM (2010) Encouraging CPAP adherence: it is everyone's job. Respir Care 55(9):1230–1239PubMed
31.
Ye L, Pack AI, Maislin G, Dinges D, Hurley S, McCloskey S, Weaver TE (2012) Predictors of continuous positive airway pressure use during the first week of treatment. J Sleep Res 21(4):419–426PubMed
32.
Manjunath SK, Sarva ST, Yataco JC, Murillo LC, Avecillas JF, Freire AX (2013) Psychiatric disorder does not preclude adequate continuous positive airway pressure titration. Am J Med Sci 346(2):104–107PubMed
33.
Maschauer EL, Fairley DM, Riha RL (2017) Does personality play a role in continuous positive airway pressure compliance? Breathe (Sheff ) 13(1):32–43
34.
Ullah MI, Campbell DG, Bhagat R, Lyons JA, Tamanna S (2017) Improving PTSD symptoms and preventing progression of subclinical PTSD to an overt disorder by treating comorbid OSA with CPAP. J Clin Sleep Med 13(10):1191–1198PubMedPubMedCentral
35.
Sawyer AM, Gooneratne NS, Marcus CL et al (2011) A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 15(6):343–356PubMedPubMedCentral
36.
Brostrom A, Stromberg A, Martensson J et al (2007) Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS. J Sleep Res 16(4):439–447PubMed
37.
Starrenburg AH, Kraaier K, Pedersen SS et al (2013) Association of psychiatric history and type D personality with symptoms of anxiety, depression, and health status prior to ICD implantation. Int J Behav Med 20(3):425–433PubMed
38.
Law M, Naughton M, Ho S, Roebuck T, Dabscheck E (2014) Depression may reduce adherence during CPAP titration trial. J Clin Sleep Med 10(2):163–169PubMedPubMedCentral
39.
Ulander M, Johansson MS, Ewaldh AE, Svanborg E, Broström A (2014) Side effects to continuous positive airway pressure treatment for obstructive sleep apnoea: changes over time and association to adherence. Sleep Breath 18(4):799–807PubMed
40.
Krakow BJ, Obando JJ, Ulibarri VA et al (2017) Positive airway pressure adherence and subthreshold adherence in posttraumatic stress disorder patients with comorbid sleep apnea. Patient Prefer Adherence 11:1923–1932PubMedPubMedCentral
41.
Seto H, Nakao M (2017) Relationships between catastrophic thought, bodily sensations and physical symptoms. Biopsychosoc Med 11:28PubMedPubMedCentral
42.
Nakao M, Barsky AJ (2007) Clinical application of somatosensory amplification in psychosomatic medicine. Biopsychosoc Med 1:17PubMedPubMedCentral
43.
Krakow B, Ulibarri V, Melendrez D et al (2008) A daytime, abbreviated cardio-respiratory sleep study (CPT 95807-52) to acclimate insomnia patients with sleep disordered breathing to positive airway pressure (PAP-NAP). J Clin Sleep Med 4(3):212–222PubMedPubMedCentral
44.
Burns PB, Rohrich RJ, Chung KC (2011) The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg 128(1):305–310PubMedPubMedCentral
45.
American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
46.
Berry RB, Budhiraja R, Gottlieb DJ et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of sleep medicine. J Clin Sleep Med 8(5):597–619PubMedPubMedCentral
47.
Krakow B, Ulibarri VA, Romero E et al (2013) Adaptive servo-ventilation therapy in a case series of patients with co-morbid insomnia and sleep apnea. J Sleep Disord 2(1):1-10.
48.
Aloia MS, Knoepke CE, Lee-Chiong T (2010) The new local coverage determination criteria for adherence to positive airway pressure treatment: testing the limits? Chest 138(4):875–879PubMedPubMedCentral
49.
Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N et al (2005) Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 128(2):624–633PubMed
50.
Engleman HM, Cheshire KE, Deary IJ, Douglas NJ (1993) Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax 48(9):911–914PubMedPubMedCentral
51.
Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ (1998) Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 53(5):341–345PubMedPubMedCentral
52.
Jenkinson C, Davies RJ, Mullins R, Stradling JR (1999) Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 353(9170):2100–2105PubMed
53.
Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C (1998) Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 157(3 Pt 1):858–865PubMed
54.
Wickwire EM, Lettieri CJ, Cairns AA et al (2013) Maximizing positive airway pressure adherence in adults: a common-sense approach. Chest 144(2):680–693PubMed
55.
Zimmerman ME, Arnedt JT, Stanchina M, Millman RP, Aloia MS (2006) Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea. Chest 130(6):1772–1778PubMed
56.
Wohlgemuth WK, Chirinos DA, Domingo S et al (2015) Attempters, adherers, and non-adherers: latent profile analysis of CPAP use with correlates. Sleep Med 16(3):336–342PubMed
57.
Bao Y, Ryan AM, Shao H et al (2013) Generic initiation and antidepressant therapy adherence under Medicare part D. Am J Manag Care 19(12):989–998PubMedPubMedCentral
58.
Hornyak M, Scholz H, Kohnen R, Bengel J, Kassubek J, Trenkwalder C (2014) What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. Sleep Med Rev 18(2):153–164PubMed
59.
Billings ME, Kapur VK (2013) Medicare long-term CPAP coverage policy: a cost-utility analysis. J Clin Sleep Med 9(10):1023–1029PubMedPubMedCentral
60.
Krakow B, Ulibarri VA, McIver ND et al (2016) A novel therapy for chronic sleep-onset insomnia: a retrospective, nonrandomized controlled study of auto-adjusting, dual-level, positive airway pressure technology. Prim Care Companion CNS Disord 18(5):ejournal, no page numbers.
61.
Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, Williamson B, Windler S, McEvoy R (2011) The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 34(1):111–119PubMedPubMedCentral
62.
Faccenda JF, Mackay TW, Boon NA, Douglas NJ (2001) Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163(2):344–348PubMed
63.
Kingshott RN, Douglas NJ (2000) The effect of in-laboratory polysomnography on sleep and objective daytime sleepiness. Sleep 23(8):1109–1113PubMed
64.
Stradling JR, Davies RJ (2000) Is more NCPAP better? Sleep 23(Suppl 4):S150–S153PubMed
65.
Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, Kader G, Mahowald M, Younger J, Pack AI (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30(6):711–719PubMedPubMedCentral
66.
Metadata
Title
The PAP-NAP one decade later: patient risk factors, indications, and clinically relevant emotional and motivational influences on PAP use
Authors
Victor A. Ulibarri
Barry Krakow
Natalia D. McIver
Publication date
01-12-2020
Publisher
Springer International Publishing
Keyword
Polysomnography
Published in
Sleep and Breathing / Issue 4/2020
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-019-01988-z

Other articles of this Issue 4/2020

Sleep and Breathing 4/2020 Go to the issue

Psychiatrics • Original Article

Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment

Sleep Breathing Physiology and Disorders • Original Article

Electrical stimulation of the whole hypoglossal nerve in patients with obstructive sleep apnea

Sleep Breathing Physiology and Disorders • Letter to the Editors

Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study

Sleep Breathing Physiology and Disorders • Letter to the Editors

Response to: Obstructive sleep apnea syndrome and obesity: screening ability

Sleep Breathing Physiology and Disorders • Original Article

The impact of obstructive apnea sleep syndrome on chemical function

Sleep Breathing Physiology and Disorders • Original Article

Diagnostic performance of nocturnal oximetry in the detection of obstructive sleep apnea syndrome: a Brazilian study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits